Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients

Bisphosphonates are well known inhibitors of osteoclast activity and thus may be employed to influence osteoblast activity. The present study was designed to evaluate the in vivo effects of zoledronic acid (ZA) on the proliferation and osteoblastic commitment of mesenchymal stem cells (MSC) in osteo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Luca Dalle Carbonare, Monica Mottes, Giovanni Malerba, Antonio Mori, Martina Zaninotto, Mario Plebani, Alessandra Dellantonio, Maria Teresa Valenti
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2017-06-01
Colecção:International Journal of Molecular Sciences
Assuntos:
mesenchymal stem cells
Runt-related transcription factor 2 (RUNX2)
zoledronic acid
gene expression
bone turnover
differentiation
Acesso em linha:http://www.mdpi.com/1422-0067/18/6/1261
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados